Phase 2 Leukemia, Myeloid, Acute Clinical Trials
12 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–12 of 12 trials
Recruiting
Phase 2
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Myelodysplastic SyndromesMixed Phenotype Acute LeukemiaLeukemia, Myeloid, Acute
Orca Biosystems, Inc.80 enrolled5 locationsNCT07216443
Recruiting
Phase 1Phase 2
MB-dNPM1-TCR.1 in Relapsed/Refractory AML
Leukemia, Myeloid, Acute
Miltenyi Biomedicine GmbH29 enrolled1 locationNCT06424340
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Multiple MyelomaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+1 more
Sumitomo Pharma America, Inc.606 enrolled104 locationsNCT04988555
Recruiting
Phase 1Phase 2
Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse
Leukemia, Myeloid, Acute
Zhujiang Hospital20 enrolled1 locationNCT05270200
Recruiting
Phase 2
Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML
Leukemia, Myeloid, AcuteRefractory LeukemiaRelapsed Adult AML
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT05305859
Recruiting
Phase 2
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
Leukemia, Myeloid, Acute
OncoVerity, Inc.120 enrolled31 locationsNCT06384261
Recruiting
Phase 1Phase 2
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Leukemia, Myeloid, Acute
Delta-Fly Pharma, Inc.39 enrolled4 locationsNCT06382168
Recruiting
Phase 1Phase 2
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Leukemia, Myeloid, Acute+2 more
Aptose Biosciences Inc.240 enrolled34 locationsNCT03850574
Recruiting
Phase 1Phase 2
Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Leukemia, Myeloid, Acute
Guangzhou Bio-gene Technology Co., Ltd24 enrolled3 locationsNCT06118788
Recruiting
Phase 2
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, AcuteAML Stage, Adult
The First Affiliated Hospital of Xiamen University66 enrolled1 locationNCT05603884
Recruiting
Phase 1Phase 2
Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT
Leukemia, Myeloid, Acute
Sichuan University77 enrolled1 locationNCT05682755
Recruiting
Phase 2Phase 3
Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT
Stem Cell Transplant ComplicationsLeukemia, Myeloid, AcuteLeukemia Relapse
Peking University People's Hospital55 enrolled1 locationNCT03793517